Home > Healthcare > Drug Device Combination > Therapeutic Systems > Anal Fistula Treatment Market

Anal Fistula Treatment Market Share

  • Report ID: GMI8425
  • Published Date: Mar 2024
  • Report Format: PDF

Anal Fistula Treatment Market Share

The anal fistula treatment industry is fragmented in nature, with various large multinationals and small and mid-sized companies competing in the industry. The development and launch of novel treatments with improved efficiency and cost-effectiveness are among a key market strategy for anal fistula treatment products manufacturers. Some of the leading industry players including Becton, Dickinson and Company, Boston Scientific Corporation, Cook Medical, and Integra LifeSciences Holdings Corporation, among others have a substantial presence in the market.

 

Anal Fistula Treatment Market Companies

Some of the eminent market participants operating in the anal fistula treatment industry include:

  • AbbVie
  • Becton, Dickinson and Company
  • Biolitec AG
  • Boston Scientific Corporation
  • Coloplast Group
  • Cook Medical
  • Gem srl
  • Integra LifeSciences Holdings Corporation
  • KARL STORZ SE & Co. KG
  • Medtronic plc
  • Teleflex Incorporated
  • Zydus Lifesciences Limited
Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Anal fistula treatment industry reached USD 728.5 million in revenue in 2023 and is set to expand at 4.4% CAGR over 2024-2032 attributed to the increasing prevalence of inflammatory bowel diseases, and the growing aging population.

The surgical segment generated more than USD 328 million in 2023 and is estimated to record substantial growth through 2032 owing to the increasing adoption of surgical treatments in minimizing symptomatic discomfort associated with anal fistulas.

North America anal fistula treatment industry accounted for USD 295 million in revenue in 2023 and is set to exhibit robust growth through 2032 driven by the robust healthcare infrastructure, extensive R&D initiatives, and a high prevalence of inflammatory bowel diseases across the region.

Some of the leading firms engaged in the anal fistula treatment industry are AbbVie, Becton, Dickinson, and Company, Biolitec AG, Boston Scientific Corporation, Coloplast Group, Cook Medical, Gem srl, KARL STORZ SE & Co. KG, Medtronic plc, Teleflex Incorporated, and Zydus Lifesciences Limited.

Anal Fistula Treatment Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 12
  • Tables & Figures: 307
  • Countries covered: 22
  • Pages: 180
 Download Free Sample